Bright Green Corp

Bright Green Corp went public through a direct listing on Nasdaq Capital Market on May 17, 2022, with a reference price of $2.00. Dentons advised the company and Carmel, Milazzo & Feil advised the underwriters.

Bright Green Corp seeks to produce federally legal cannabis in the United States. It has conditional approval from the U.S. Drug Enforcement Administration and a Memorandum of Agreement with the agency permitting it to pursue federal registration for bulk manufacturing of cannabis.

Status

Direct listing

Exchange

Nasdaq Capital Market

Listed

May 17, 2022

Price

$2.00

First filed

Mar 29, 2022

Company counsel

Dentons

Underwriters' counsel

Carmel, Milazzo & Feil

Sector

Biotech & pharma

Country / state

FL